TrialPaediatric drugs2021

Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.

Amy S Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.